Cambridge Healthtech Institute’s 6th Annual

AI/Machine Learning for Early Drug Discovery – Part 1

AI-Driven Decision-Making for Drug Design, Screening, and Lead Optimization

APRIL 2 - 3, 2024

Artificial Intelligence (AI)/Machine Learning (ML) for Early Drug Discovery is a two-part conference that brings together a diverse group of experts from chemistry, target discovery, pharmacology, and bioinformatics to talk about the increasing use of computational tools, models, algorithms, and data analytics for drug development. The talks will highlight the pros and cons of AI/ML-driven decision-making using relevant case studies from small molecule and peptide drug development. The first part of the conference will focus on how AI/ML can help improve drug design, hit identification, and lead optimization.